Author | S. Vincent Rajkumar, MD | OncLive

Author | S. Vincent Rajkumar, MD


Dr. Rajkumar on Quadruplet Regimens in Multiple Myeloma Treatment

June 20, 2019


S. Vincent Rajkumar, a professor of Medicine at the Mayo Clinic, Rochester, Minnesota, discusses the prevalence of quadruplet regimens in treating patients with multiple myeloma.

Dr. Rajkumar on Significance of SWOG S0777 Study for Multiple Myeloma

April 04, 2016


S. Vincent Rajkumar, MD, professor of Medicine at Mayo Clinic, discusses the significance of the phase III SWOG S0777 study, which looked at bortezomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with previously untreated multiple myeloma.